A new study reveals many benzodiazepine users are misinformed about the risks of withdrawal and experience devastating consequences.
Current long-term users of benzodiazepines and Z-drugs identify barriers and facilitators for discontinuation.
The FDA has finally acknowledged the adverse effects of benzodiazepines, the dangers of withdrawal, and that the current packaging does not sufficiently warn of these harms.
This week on MIA Radio, we present the second part of our podcast to join in the events for World Benzodiazepine Awareness Day 2020...
Recent research implicates benzodiazepines as being involved in a high rate of emergency department visits in the US.
Benzodiazepine prescription practices may be in response to an epidemic of distress, rather than being used to treat specific mental health diagnoses.
White race and size of initial prescription, along with poor sleep quality, are associated with long-term benzodiazepine use in older adults.
Although opioid addiction and overuse have garnered significant national attention, similar trends in benzodiazepine overprescription and overuse continue to go unnoticed.
Long-term benzodiazepine use shown to effect cognitive function during current use and for years after drug discontinuation.
Researchers Identify risk factors for long-term benzodiazepine use to prevent harmful effects.
The researchers found that, of those who were initially prescribed both antidepressants and benzodiazepines, approximately 12% went on to engage in long-term benzodiazepine use.
A new study reported on in Medscape, examined risk factors for misuse of benzodiazepines (drugs such as Xanax, Ativan, and Klonopin). The researchers found that patients who had been prescribed the medication on an as-needed basis were more likely to end up abusing it than those who had been prescribed a standing dose.
A recent review found that hypnotic medications are associated with risks of suicide and suicidal ideation.